Robert N. Fried - 30 Jun 2026 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: NAGE
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jul 2026, 17:16:50 UTC
Prior SEC filing: 27 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeong James Lee, Attorney-in-Fact

Key filing fact

Robert N. Fried filed Form 4 for Niagen Bioscience, Inc. (NAGE) on 08 Jul 2026.

Key facts

This page summarizes Robert N. Fried's Form 4 filing for Niagen Bioscience, Inc. (NAGE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jul 2026, 17:16.

Change

Previous filing in this sequence was filed on 27 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001417952 Primary reporting owner

Fried Robert N

Relationship: Chief Executive Officer, Director
Address: 10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES
Signature: /s/ Jeong James Lee, Attorney-in-Fact
Signature date: 08 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAGE transaction

Common Stock

Award

Transaction value
Shares: +1,106
Change %: +0.1%
Price: $2.71^*
Shares after: 1,060,087
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

NAGE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 95,001
Date: 30 Jun 2026
Ownership: By Fried-Travis Revocable Trust U/A Dated 06/02/1999

NAGE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 250,000
Date: 30 Jun 2026
Ownership: By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020
Footnotes: F2

NAGE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 250,000
Date: 30 Jun 2026
Ownership: By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020
Footnotes: F2

NAGE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,746
Date: 30 Jun 2026
Ownership: See Footnote
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d).

Footnote F2

The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Footnote F3

6,745 shares of Common Stock held by Jeremy Fried and 6,001 shares of Common Stock held by Benjamin Fried, who are sons of Robert Fried.